Infinium Pharmachem Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Infinium Pharmachem Limited's successfully completed its Initial Public Offering and commenced trading on Apr 17, 2023 at the NSE exchange. The company raised 18,75,000 Shares through this public offering, comprising 18,75,000 Shares in fresh capital.
The IPO was priced within the band of ₹135 to ₹135, with minimum application lots of 1000 shares. The offering attracted significant investor interest during its subscription period from Mar 31, 2023 to Apr 05, 2023.
Share allotment was finalized on Apr 11, 2023, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
NA
NA
- Mr. Sanjaykumar Viththalbhai Patel
- Mr. Pravin Bhadabhai Madhani
- Mr. Mitesh Lavjibhai Chikhaliya
Infinium Pharmachem Limited
Bigshare Services Private Limited